Related Experiment Video
Updated: Mar 26, 2026
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
Advances in microfluidics in combating infectious diseases
Andy Tay1, Andrea Pavesi2, Saeed Rismani Yazdi3
1BioSystems and Micromechanics (BioSyM) IRG, Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore 138602, Singapore; Department of Biomedical Engineering, National University of Singapore, Singapore 117575, Singapore; Department of Bioengineering, University of California Los Angeles, CA 90025, United States.
Microfluidic devices offer low-cost, user-friendly point-of-care diagnostics for infectious diseases like malaria, sepsis, and HIV, especially benefiting resource-poor settings. This technology aims to improve global health outcomes through accessible disease detection.
Area of Science:
- Biomedical Engineering
- Medical Diagnostics
- Public Health
Background:
- Developing affordable and accessible healthcare technologies is a key scientific pursuit.
- Microfluidics has emerged as a promising field for low-cost diagnostics, particularly for infectious diseases in resource-limited areas.
Purpose of the Study:
- To provide an overview of recent advancements in microfluidic devices for point-of-care (POC) diagnostics.
- To focus on the application of these devices for diagnosing malaria, sepsis, and AIDS/HIV.
- To briefly discuss other significant infectious diseases like SARS, tuberculosis, and dengue.
Main Methods:
- Review of current research in microfluidic device development for infectious disease diagnostics.
- Emphasis on devices suitable for point-of-care applications.
- Analysis of disease burden using disability-adjusted life-years (DALYs) from the World Health Organization (WHO).
Main Results:
- Microfluidic technologies are advancing for rapid and cost-effective POC diagnosis of major infectious diseases.
- Significant progress has been made in devices targeting malaria, sepsis, and AIDS/HIV.
- The potential for broader application to other infectious diseases is being explored.
Conclusions:
- Microfluidic POC diagnostics hold great promise for improving healthcare access and outcomes globally, especially in underserved regions.
- Continued research and development are crucial to overcome challenges and realize the full potential of these technologies.
- Future applications will focus on expanding the range of detectable diseases and enhancing device usability.
